{"id":31503,"date":"2021-06-02T20:36:00","date_gmt":"2021-06-02T20:36:00","guid":{"rendered":"https:\/\/beyondtype2.org\/resources\/attd2021-noticias-de-ultima-hora\/"},"modified":"2021-06-02T20:36:00","modified_gmt":"2021-06-02T20:36:00","slug":"attd2021-noticias-de-ultima-hora","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/","title":{"rendered":"Noticias de \u00daltima Hora desde ATTD 2021"},"content":{"rendered":"<p><em><strong>Nota del Editor:<\/strong> ATTD es una conferencia de tecnolog&iacute;a que proporciona una plataforma para que los m&eacute;dicos, cient&iacute;ficos y la comunidad de diabetes presente y debata conocimientos sobre la tecnolog&iacute;a y el tratamiento de la diabetes. Este art&iacute;culo se actualizar&aacute; peri&oacute;dicamente con noticias y anuncios de &uacute;ltima hora durante el transcurso de la Conferencia ATTD. &iexcl;Visita con frecuencia! Sigue nuestra cobertura en Twitter con el hashtag # ATTD2021<\/em><\/p>\n<hr>\n<h3><em>MI&Eacute;RCOLES,&nbsp; 2 DE JUNIO 2, 2021<\/em><\/h3>\n<ul>\n<li><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31144428\/\" target=\"_blank\" rel=\"noopener noreferrer\">En un estudio de un a&ntilde;o realizado por investigadores del Hospital Universitario de Amberes<\/a>, se encontr&oacute; que los participantes que cambiaron insulina regular a insulina de acci&oacute;n ultra r&aacute;pida tuvieron un aumento del cinco por ciento en el tiempo en rango, el equivalente a 75 minutos por d&iacute;a.<\/li>\n<li>En un ensayo controlado aleatorio multic&eacute;ntrico de 6 meses que compar&oacute; el monitoreo continuo de glucosa en tiempo real (rtCGM) y el monitoreo continuo de glucosa escaneada intermitentemente (isCGM), se encontr&oacute; que <a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)00789-3\/fulltext#seccestitle10\" target=\"_blank\" rel=\"noopener noreferrer\">la rtCGM estaba asociada con un mayor tiempo en el rango y menor HbA1c<\/a>. La reacci&oacute;n cut&aacute;nea fue m&aacute;s com&uacute;n con isCGM y se report&oacute; sangrado con mayor frecuencia con rtCGM.<\/li>\n<li>Basado en National Health y datos de la Encuesta de Examen de Nutrici&oacute;n (NHANES), un ensayo cl&iacute;nico aleatorizado que incluy&oacute; a 175 adultos con diabetes tipo 2, durante un curso de ocho meses, <a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2780593\" target=\"_blank\" rel=\"noopener noreferrer\">los niveles de HbA1c de los participantes disminuyeron significativamente con el monitoreo continuo de glucosa en comparaci&oacute;n con el monitoreo de glucosa en sangre<\/a> (-1,1 por ciento frente a -0,6 por ciento). por ciento).<\/li>\n<p>https:\/\/beyondtype1.org\/es\/wp-content\/uploads\/2021\/06\/Kayla-Hui_headshot.png<\/p>\n<p>Kayla Hui es Reportera de Salud en Beyond Type 1 y se encargar&aacute; de cubrir temas relacionados con diabetes, enfermedades cr&oacute;nicas e inequidades en salud. Recibi&oacute; su Maestr&iacute;a en Salud P&uacute;blica de la Escuela de Salud P&uacute;blica de la Universidad de Boston. Kayla gan&oacute; una beca del Centro Pulitzer y un premio de la Fundaci&oacute;n Slants en 2020 por su proyecto sobre la salud mental de los inmigrantes chinos conductores de camiones. Puedes leer su trabajo publicado en Healthline, Verywell Health, Pulitzer Center y m&aacute;s. Fuera del horario laboral, a Kayla le gusta escalar rocas, hornear y comprar plantas que no necesita. Puedes seguirla en twitter como @kaylanhui<\/p>\n<p>kayla-piece|LatestHome|news<\/p>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Nota del Editor: ATTD es una conferencia de tecnolog&iacute;a que proporciona una plataforma para que los m&eacute;dicos, cient&iacute;ficos y la comunidad de diabetes presente y debata conocimientos sobre la tecnolog&iacute;a y el tratamiento de la diabetes. Este art&iacute;culo se actualizar&aacute; peri&oacute;dicamente con noticias y anuncios de &uacute;ltima hora durante el transcurso de la Conferencia ATTD. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":31505,"comment_status":"open","ping_status":"open","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-31503","resources","type-resources","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-2","tags-kayla-piece","tags-latesthome","tags-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Noticias de \u00daltima Hora desde ATTD 2021 | Beyond Type 1<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Noticias de \u00daltima Hora desde ATTD 2021 | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"Nota del Editor: ATTD es una conferencia de tecnolog&iacute;a que proporciona una plataforma para que los m&eacute;dicos, cient&iacute;ficos y la comunidad de diabetes presente y debata conocimientos sobre la tecnolog&iacute;a y el tratamiento de la diabetes. Este art&iacute;culo se actualizar&aacute; peri&oacute;dicamente con noticias y anuncios de &uacute;ltima hora durante el transcurso de la Conferencia ATTD. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/\",\"name\":\"Noticias de \u00daltima Hora desde ATTD 2021 | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg\",\"datePublished\":\"2021-06-02T20:36:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg\",\"width\":2048,\"height\":733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Noticias de \u00daltima Hora desde ATTD 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Noticias de \u00daltima Hora desde ATTD 2021 | Beyond Type 1","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/","og_locale":"es_ES","og_type":"article","og_title":"Noticias de \u00daltima Hora desde ATTD 2021 | Beyond Type 1","og_description":"Nota del Editor: ATTD es una conferencia de tecnolog&iacute;a que proporciona una plataforma para que los m&eacute;dicos, cient&iacute;ficos y la comunidad de diabetes presente y debata conocimientos sobre la tecnolog&iacute;a y el tratamiento de la diabetes. Este art&iacute;culo se actualizar&aacute; peri&oacute;dicamente con noticias y anuncios de &uacute;ltima hora durante el transcurso de la Conferencia ATTD. [&hellip;]","og_url":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","og_image":[{"width":2048,"height":733,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/","url":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/","name":"Noticias de \u00daltima Hora desde ATTD 2021 | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg","datePublished":"2021-06-02T20:36:00+00:00","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-BT2-HEADER-2021-ATTD-2.jpeg","width":2048,"height":733},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/attd2021-noticias-de-ultima-hora\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"Noticias de \u00daltima Hora desde ATTD 2021"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/31503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=31503"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/31503\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/31505"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=31503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}